Indication
Serum sickness
Serum sickness is a systemic type III immune-complex-mediated hypersensitivity reaction that arises following exposure to foreign antigens, historically heterologous animal antisera and currently therapeutic biologic agents or foreign proteins. Read more about Serum sickness
340 drugs 164 manufacturers
Drugs that treat it
Common Serum sickness therapies.
DEXAMETHASONE
DEXAMETHASONE
CORTISONE ACETATE
DEXAMETHASONE SODIUM PHOSPHATE
PREDNISONE
SOLU-MEDROL (methylprednisolone sodium succinate)
METHYLPREDNISOLONE
METHYLPREDNISOLONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSerum sickness is a systemic type III immune-complex-mediated hypersensitivity reaction that arises following exposure to foreign antigens, historically heterologous animal antisera and currently therapeutic biologic agents or foreign proteins.
It develops when circulating antibodies bind to the offending antigen, forming immune complexes that deposit within small blood vessel walls across various organs, predominantly affecting the skin, joints, and kidneys.
This deposition triggers classical complement pathway activation, resulting in hypocomplementemia and localized vascular inflammation.
Clinically, it characteristically manifests one to two weeks following exposure with a classic triad of fever, an urticarial or morbilliform cutaneous rash, and polyarthralgia or arthritis, frequently accompanied by lymphadenopathy.
- nih.gov
Serum sickness is a systemic type III immune-complex-mediated hypersensitivity reaction that arises following exposure to foreign antigens, historically heterologous animal antisera and currently therapeutic biologic agents or foreign proteins Clinically, it characteristically manifests one to two weeks following exposure with a classic triad of fever, an urticarial or morbilliform cutaneous rash, and polyarthralgia or arthritis, frequently accompanied by lymphadenopathy
- nih.gov
Serum sickness is a systemic type III immune-complex-mediated hypersensitivity reaction that arises following exposure to foreign antigens, historically heterologous animal antisera and currently therapeutic biologic agents or foreign proteins
- nih.gov
It develops when circulating antibodies bind to the offending antigen, forming immune complexes that deposit within small blood vessel walls across various organs, predominantly affecting the skin, joints, and kidneys This deposition triggers classical complement pathway activation, resulting in hypocomplementemia and localized vascular inflammation
- nih.gov
It develops when circulating antibodies bind to the offending antigen, forming immune complexes that deposit within small blood vessel walls across various organs, predominantly affecting the skin, joints, and kidneys This deposition triggers classical complement pathway activation, resulting in hypocomplementemia and localized vascular inflammation
- miami.edu
Clinically, it characteristically manifests one to two weeks following exposure with a classic triad of fever, an urticarial or morbilliform cutaneous rash, and polyarthralgia or arthritis, frequently accompanied by lymphadenopathy
Personalize your experience
Follow Serum sickness and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.